Skip to Content

Nippon Shinyaku Co Ltd NPNKF

Morningstar Rating
$41.82 −14.48 (25.72%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NPNKF is trading at a 884% premium.
Price
$55.08
Fair Value
$68.62
Uncertainty
Very High
1-Star Price
$889.31
5-Star Price
$66.33
Economic Moat
Xbx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NPNKF is a good fit for your portfolio.

Trading Information

Previous Close Price
$56.30
Day Range
$41.8241.82
52-Week Range
$41.8255.55
Bid/Ask
$18.74 / $22.04
Market Cap
$2.82 Bil
Volume/Avg
26,911 / 24,911

Key Statistics

Price/Earnings (Normalized)
20.05
Price/Sales
3.48
Dividend Yield (Trailing)
1.54%
Dividend Yield (Forward)
1.54%
Total Yield
1.54%

Company Profile

Nippon Shinyaku Co Ltd is a specialty and generic drug manufacturing company. Nippon's research and development activities include a focus on pharmaceuticals, nutraceuticals, safety and pharmacokinetics of drug seeds, genomic drug discovery, and nucleic acid drugs. The company also develops health food ingredients, preservatives, protein preparations, and spices. Nippon considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Value
Total Number of Employees
2,186

Comparables

Valuation

Metric
NPNKF
4554
4577
Price/Earnings (Normalized)
20.0512.5011.94
Price/Book Value
2.510.800.70
Price/Sales
3.480.820.81
Price/Cash Flow
17.974.905.75
Price/Earnings
NPNKF
4554
4577

Financial Strength

Metric
NPNKF
4554
4577
Quick Ratio
4.170.550.82
Current Ratio
5.921.242.29
Interest Coverage
256.0258.74197.65
Quick Ratio
NPNKF
4554
4577

Profitability

Metric
NPNKF
4554
4577
Return on Assets (Normalized)
9.57%4.98%5.80%
Return on Equity (Normalized)
11.30%10.16%8.27%
Return on Invested Capital (Normalized)
10.97%6.17%7.32%
Return on Assets
NPNKF
4554
4577
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
PfmfjczrmLwtyk$81.5 Bil
Merck KGaA ADR
MKKGY
MznqzhfxjfSgrtq$80.4 Bil
Haleon PLC ADR
HLN
RfksgczmtXwbky$38.6 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
HpkjbgtmXggpy$19.1 Bil
Viatris Inc
VTRS
ZvldjwdnVgq$12.7 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
DpglpywmRdn$12.0 Bil
Catalent Inc
CTLT
XmllxrbwStbnjrt$10.1 Bil
Perrigo Co PLC
PRGO
GclphhmmJvs$3.7 Bil
Prestige Consumer Healthcare Inc
PBH
LmmzyfmjyVvtlc$3.3 Bil
Curaleaf Holdings Inc
CURLF
WsyymwpYksgf$3.2 Bil

Sponsor Center